Home > Income Statement > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Consolidated Net Profit

    Back to Income Statement
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹9,576 Cr₹8,474 Cr₹3,273 Cr₹2,904 Cr₹3,765 Cr

What is the latest Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES ?

The latest Consolidated Net Profit ratio of SUN PHARMACEUTICAL INDUSTRIES is ₹9,576 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹9,576 Cr
Mar2023₹8,474 Cr
Mar2022₹3,273 Cr
Mar2021₹2,904 Cr
Mar2020₹3,765 Cr

How is Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹9,576 Cr
13.01
Mar2023 ₹8,474 Cr
158.91
Mar2022 ₹3,273 Cr
12.70
Mar2021 ₹2,904 Cr
-22.87
Mar2020 ₹3,765 Cr -

Compare Consolidated Net Profit of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹443,018.7 Cr -0.4% 4.7% 60.2% Stock Analytics
DIVIS LABORATORIES ₹144,299.0 Cr -1.1% 11% 43.2% Stock Analytics
CIPLA ₹132,316.0 Cr -1.3% 2.8% 33.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,579.0 Cr -2.3% -7.8% 14.4% Stock Analytics
ZYDUS LIFESCIENCES ₹106,092.0 Cr -5.7% -12.6% 68.7% Stock Analytics
MANKIND PHARMA ₹97,396.6 Cr -2.7% 6.6% 33.4% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-0.4%

4.7%

60.2%

SENSEX

0.3%

3%

23.3%


You may also like the below Video Courses